Deletion of DWORF does not affect cardiac function in aging and in PLN-R14del cardiomyopathy

Nienke M Stege1, Vivian Oliveira Nunes Teixeira1, Sietske N Zijlstra1

  • 1Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

Insights

Deleting the dwarf open reading frame (DWORF) gene does not worsen cardiomyopathy caused by the phospholamban (PLN) R14del variant in mice. DWORF is not essential for normal heart function during aging.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Genetic Models of Heart Disease

Background:

  • The phospholamban (PLN) p.Arg14del variant causes cardiomyopathy and heart failure (HF).
  • Dwarf open reading frame (DWORF) counteracts PLN in the sarcoplasmic reticulum and can delay disease in PLN-R14del mice.
  • The effect of DWORF absence on PLN-R14del cardiomyopathy progression was unknown.

Purpose of the Study:

  • To investigate if deleting DWORF accelerates age-dependent cardiomyopathy in wild-type (WT) and PLN-R14del mice.
  • To determine if DWORF is essential for cardiac function during aging.

Main Methods:

  • Generation and aging of DWORF-deleted (DWORF-/-) mice and PLN-R14del (R14-/-) mice, some with combined DWORF and R14 deletions.
  • Assessment of cardiac function, including left ventricular ejection fraction (LVEF), over time.
  • Analysis of gene expression markers for cardiac remodeling and fibrosis, and histological evaluation of cardiac fibrosis.

Main Results:

  • DWORF-/- mice showed normal cardiac function and LVEF throughout aging compared to WT controls.
  • R14-/- mice developed reduced LVEF by 18 months of age, but DWORF deletion did not accelerate this decline.
  • Absence of DWORF did not increase cardiac remodeling, fibrosis markers, or fibrosis in R14-/- mice.

Conclusions:

  • DWORF deletion does not accelerate or exacerbate PLN-R14del cardiomyopathy in mice.
  • DWORF is dispensable for maintaining cardiac function during aging in mice.
  • DWORF gene expression changes are unlikely to explain clinical variability in human PLN-R14del cardiomyopathy.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
802
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
968